Impax sells Taiwan plant, strikes Rytary supply deal with Bora Pharmaceuticals

3rd January 2018 Uncategorised 0

When Impax Laboratories CEO Paul Bisaro started cutting costs at the struggling drug company, one move involved the “difficult decision” to let go of its manufacturing site in Taiwan, even though issues at the plant had contributed to the company’s problems. Impax now has a buyer for the facility.

More: Impax sells Taiwan plant, strikes Rytary supply deal with Bora Pharmaceuticals
Source: fierce